Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2007
12/06/2007CA2653672A1 Dihydro-pyrrolopyridine, dihydro-pyrrolopyridazine and dihydro-pyrrolopyrimidine derivatives and their use
12/06/2007CA2653529A1 Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
12/06/2007CA2653506A1 Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases
12/06/2007CA2653329A1 Triazole compounds that modulate hsp90 activity
12/06/2007CA2653136A1 Heterobicylic metalloprotease inhibitors
12/06/2007CA2653131A1 Heterobicyclic metalloprotease inhibitors
12/06/2007CA2653076A1 Pyrazolo [1, 5-a] pyrimidines as cdk inhibitors
12/06/2007CA2652849A1 Process useful in the preparation of morphinan antagonists
12/06/2007CA2652846A1 Process for the demethylation of oxycodone and related compounds
12/06/2007CA2652167A1 Pyrrolo[1,2-a]pyrazin-1(2h)-one and pyrrolo[1,2-d][1,2,4]triazin-1(2h)-one derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
12/06/2007CA2652044A1 Pyrrolopyrimidine compounds and their uses
12/06/2007CA2651979A1 Triazolopyridazine derivatives
12/06/2007CA2651549A1 Aldosterone synthase and/or 11.beta.-hydroxylase inhibitors
12/05/2007EP1862442A1 Process for oxidation of organic compounds
12/05/2007EP1861405A1 Method of reducing alpha, beta- unsaturated ketones in opioid compositions
12/05/2007EP1861404A1 Polymorphic form of 6- (4-chlorophenyl) -2, 2-dimethyl-7-phenyl-2, 3-dihydro-lh-pyrrolizin-5-ylacetic acid
12/05/2007EP1499319B1 Bicyclo 4.4.0 antiviral derivatives
12/05/2007EP1362844B1 Benzylamine analogue
12/05/2007CN101084220A Halogen substituted benzodiazepine derivatives
12/05/2007CN101084219A Pyrazolo(1,5-alpha)pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists
12/05/2007CN101084218A Imidazotriazines as protein kinase inhibitors
12/05/2007CN101084195A 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
12/05/2007CN101083986A Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (scd)
12/05/2007CN101081851A Preparation method of alpha-aza toroid drug template
12/05/2007CN100352807C Chemical compounds
12/04/2007US7304083 2-iminoimidazole derivatives (2)
12/04/2007US7304081 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/04/2007US7304077 Asthma, rhinitis therapy
12/04/2007US7304069 Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5α]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related thereto
12/04/2007US7304068 Viricide against herpes virus; 3-(2-Fluoropyridin-4-yl)-2-phenyl-7-pyrrolidin-1-ylpyrazolo[1,5-a]pyrimidine; chemical synthesis
12/04/2007US7304067 (S)-2-[(R)-5-[4-(4-amino-pyrimidin-5-yl)-benzyl]-7-(3,5-dichloro-phenyl)-5-methyl-6-oxo-6,7-dihydro-5H-imidazo[1,2- alpha ]imidazole-3-sulfonylamino]-N-(2-hydroxy-ethyl)-propionamide; inhibit interaction of CAMs and Leukointegrins; are metabolized at a rate that is not overly rapid; antiinflammatories
12/04/2007US7304064 1-[(indol-3-yl)carbonyl]piperazine derivatives
12/04/2007US7304052 Irritable bowel syndrome; gastrointestinal disorders
12/04/2007US7304050 Antibacterial agents
12/04/2007US7304049 Succinamides N-monosubstituted with with a dibenzo[b,e]azepinone group that inhibit the production of A beta-peptide, acting to prevent the formation of neurological deposits of amyloid protein; treating Alzheimer's Disease
12/04/2007US7303926 Causing necrosis or apoptosis of target tissue using both type 1 and type 2 mechanisms
11/2007
11/29/2007WO2007136692A2 Crystalline forms of 5-chloro-6- (2, 6-difluoro-4- [3- (methylamino) propoxy] phenyl)-n-((1s)-2, 2, 2,-trifluoro-1-methylethyl] [1,2,4] triazolo [1,5-a] pyrimidin-7-amine salts
11/29/2007WO2007136325A1 1- [ (4- [benzoyl (methyl) amino] -3- (phenyl) butyl] azetidine derivatives for the treatment of gastrointestinal disorders 2
11/29/2007WO2007135890A1 Novel compound having affinity for amyloid
11/29/2007WO2007135121A1 Novel 8,10-diaza-bicyclo[4.3.1]decane derivatives and their medical use
11/29/2007WO2007134986A1 Pyridopyrimidinone derivatives
11/29/2007WO2007134828A1 Pyrazolo [3, 4-d] pyrimidine derivatives useful to treat respiratory disorders
11/29/2007WO2007134485A1 Aporphine and oxoaporphine compounds and pharmaceutical use thereof
11/29/2007WO2007134434A1 Phenanthrene derivatives as mpges-1 inhibitors
11/29/2007WO2007134362A1 2-ARYLPYRAZOLO[L,5-α]PYRIMIDIN-3-YL ACETAMIDE DERIVATIVES AS LIGANDS FOR TRANSLOCATOR PROTEIN (18 KDA)
11/29/2007WO2007115620A3 Novel cyclobutyl compounds as kinase inhibitors
11/29/2007WO2007084882A3 Process for the preparation of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid amides and intermediates used therein
11/29/2007WO2006072612A3 Triazolophthalazines as pde2- inhibitors
11/29/2007US20070275987 2-Benzyloxymethyl-3H-pyrido[2,3-d]pyrimidin-4-one; 2-[2-(3-Chloro-phenyl)-ethyl]-3H-pyrido[2,3-d]pyrimidin-4-one; dyslipidemia, atherosclerosis, diabetes, metabolic syndrome
11/29/2007US20070275985 Triazolopyrimidines
11/29/2007US20070275983 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
11/29/2007US20070275972 Pyridopyrazines and the use thereof as kinase inhibitors
11/29/2007US20070275964 Cannabinoid receptor ligands and uses thereof
11/29/2007US20070275961 Triazolo ' 1, 5-A ! Pyrimidines and Their Use in Medicine
11/29/2007US20070275959 Carbamoyl Esters That Inhibit Cholinesterase And Release Pharmacologically Active Agents
11/29/2007US20070275947 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
11/29/2007US20070275930 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
11/29/2007US20070275912 Nucleoside derivatives as inhibitors of rna-dependent RNA viral polymerase
11/29/2007US20070275911 Targeted Drug-Formaldehyde Conjugates and Methods of Making and Using the Same
11/29/2007CA2653783A1 Novel compound having affinity for amyloid
11/29/2007CA2652238A1 Phenanthrene derivatives as mpges-1 inhibitors
11/29/2007CA2651677A1 2-arylpyrazolo[l,5-.alpha.]pyrimidin-3-yl acetamide derivatives as ligands for translocator protein (18 kda)
11/29/2007CA2651579A1 Integrase inhibitors
11/29/2007CA2650916A1 Crystalline forms of 5-chloro-6-(2,6-difluoro-4-[3-(methylamino)propoxy]phenyl)-n-[(1s)-2,2,2-trifluoro-1-methylethyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine salts
11/29/2007CA2650661A1 Pyrazolo [3, 4-d] pyrimidine derivatives useful to treat respiratory disorders
11/29/2007CA2650611A1 Compositions and methods for fgf receptor kinases inhibitors
11/28/2007EP1860107A1 Photosensitive compound
11/28/2007EP1859952A1 Optical information recording medium and optical information recording method
11/28/2007EP1858896A1 Diaza-spiro-[4.4]-nonane derivatives as neurokinin (nk1) antagonists
11/28/2007EP1858895A2 Piperazine-piperidines with cxcr3 antagonist activity
11/28/2007EP1858888A2 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity
11/28/2007EP1858883A2 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors
11/28/2007EP1858521A2 Compounds and compositions as protein kinase inhbitors
11/28/2007EP1554279B1 Process for the preparation of zaleplon
11/28/2007EP1458395B1 Medical use of gsk3-inhibiting oxindole derivatives
11/28/2007CN101080410A 7-amino-6-heteroaryl-1,2,4-triazolo[1,5-a]pyrimidines and to the use thereof for combating pathogenic fungi
11/28/2007CN101080409A 7-amino-6-hetaryl-1,2,4-triazolo[1,5-a]pyrimidine compounds and the use thereof for controlling pathogenic fungi
11/28/2007CN101080408A Trycyclic heterocycles, their manufacture and use as pharmaceutical agents
11/28/2007CN101080394A Heterocyclical chromophore architectures
11/28/2007CN101077871A Method for preparing copper chlorphyllin from silkworm excrement by using tap water
11/28/2007CN101077870A Method for preparing triazolepyrimidine compounds
11/28/2007CN100351255C Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
11/28/2007CN100351254C Bisphenols monomer with imide structure and its synthesis
11/28/2007CN100351253C Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
11/28/2007CN100351249C Quinolinone derivatives as tyrosine kinase inhibitors
11/27/2007US7301023 Immunosuppressants; grafting of organs; rheumatic diseases
11/27/2007US7300933 Diazabicyclic biaryl derivatives
11/27/2007US7300932 For treatment or prevention of metabolic and cell proliferative diseases; modifying lipid metabolism
11/27/2007US7300908 Fungicidal triazolopyrimidines, method for the production thereof and use thereof in controlling noxious fungi and agents containing said compounds
11/27/2007US7300747 For producing optical materials such as adhesives for optical devices, coating compositions for optical devices, resist materials, prisms, fiber optics, information recording media, filters and plastic lenses
11/27/2007CA2358998C Substituted bicyclic derivatives useful as anticancer agents
11/27/2007CA2336412C Medicament for treatment of diabetes
11/27/2007CA2335328C A substituted triazolo-pyridazine derivative, pharmaceutical compositions made therefrom
11/27/2007CA2253613C Therapeutic treatment for vegf related occular diseases
11/22/2007WO2007134268A2 Biohydrogen production by an artificial enzymatic pathway
11/22/2007WO2007133805A2 Aerogel-based enclosure systems
11/22/2007WO2007133801A2 Magnetic microparticles comprising organic substances
11/22/2007WO2007133108A1 Pharmaceutical composition, method for the production and the use thereof
11/22/2007WO2007132841A1 Fused heterocyclic compound and use thereof
11/22/2007WO2007132308A1 Triazolopyrazine derivatives useful as anti-cancer agents
1 ... 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 ... 573